Lexeo Therapeutics
Company Details
Status: Public
Employees: 11-50
Location:
Lexeo Therapeutics, 430 East 29th Street, 14th Floor, New York, NY 10016, United States
Type:
sample
Technology:
sample
sample
sample
sample
About: Based in New York City, Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Building on groundbreaking research from Weill Cornell Medicine and the University of California San Diego, Lexeo partners with preeminent institutions on the cutting edge of gene therapy research. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4 associated Alzheimer's disease programs, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing and commercialization.
For more information, please visit www.lexeotx.com.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Lexeo Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.